Skip to content

Fournier Thomas MedGen

Active
Private limited companyfounded 2022active for 4 yearsRue de la Croix d'Or,Upigny 6, 5310 Eghezée, BelgiumKBO/BCE: BE 0779.703.321

From the official registers: KBO 4 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Fournier Thomas MedGen has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2,000 and a net result of €68,295. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 5% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 05-01-2022 Normal situation
Activity
General medical practice NACE 86210
Establishment units
2.326.346.743 5081 La Bruyère, since 05-01-2022
2.326.346.842 5310 Eghezée, since 05-01-2022
Financial year end
31 December
Peppol
Reachable since 10-12-2025

Board and ownership

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€101,545
▲ 11.0%
Turnover
≈ €190,000
estimated
Profit
€68,295
▲ 16.1%
Equity
€2,000
▼ 98.7%
Total assets
€222,566
▲ 8.6%
Filed on 27-08-2026, 27 days after the deadlineat the National Bank
Score breakdownraises riskEquity €2,000 (0.9% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.95, cash €163,180Size: total assets €222,566Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 27% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 26-74
equity 0.9% of total assets
Liquidity 50-44
short-term debt 97.8% · cash 73.3%
Profitability 100=
return on assets 30.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026highest value
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 5% of them on solvency, 20% on liquidity, 80% on profitability and 2% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 0.95, cash €163,180
NBB · annual accounts
lowers risk · Size: total assets €222,566
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €2,000 (0.9% of total assets)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · A punctual record breaks
This company filed 3 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 4 filings
Deviation from the deadline
2025
27 days late
2024
19 days early
2023
32 days early
2022
21 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 11 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 11 July (3 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Key points

  • Caution: Equity fell in 2025from €158,190 to €2,000 ▼ 98.7% View
  • Caution: Lower solvency than 94% of companies in human healthsector median 63.0% · 20,678 companies 0.9% View

Comparable companies

These companies have the same main activity as Fournier Thomas MedGen: general medical practice (NACE 86210). They are comparable in size and age: total assets between €207,000 and €236,000, founded between 2021 and 2022.

CompanyTotal assetsGross margin
Fournier Thomas MedGen Eghezée€222,566€101,545
Société Médicale EVEIL & SANTE Eghezée€218,980€100,941
VDHD H MEDICAL Chimay€225,845€98,620
Dr. M. Vanheeswyck Hasselt€221,670€106,310
Dokter Oelbrandt Lore Mechelen€207,318€102,890
Dr. De Belder Jonas - Huisarts Beveren-Kruibeke-Zwijndrecht€225,431€104,174
Docteur Jan Bafort Burdinne€236,182€103,610
Full comparison

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Fournier Thomas MedGen

What is the company number of Fournier Thomas MedGen?
The company number of Fournier Thomas MedGen is 0779.703.321. The VAT number is the same number with BE in front: BE 0779.703.321.
Where is Fournier Thomas MedGen based?
The registered office is at Rue de la Croix d'Or,Upigny 6, 5310 Eghezée.Company details
What does Fournier Thomas MedGen do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Fournier Thomas MedGen?
The legal form of Fournier Thomas MedGen is Private limited company (BV).
When was Fournier Thomas MedGen founded?
Fournier Thomas MedGen was founded on 05-01-2022.
Is Fournier Thomas MedGen still active?
Yes, Fournier Thomas MedGen is an active enterprise in the KBO register.
What is the turnover of Fournier Thomas MedGen?
The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €101,545 and 30 comparable companies (NACE 86210). It probably lies between €150,000 and €230,000.Financials
Is Fournier Thomas MedGen profitable?
In financial year 2025, Fournier Thomas MedGen made a profit of €68,295.
Where can I find the annual accounts of Fournier Thomas MedGen?
Fournier Thomas MedGen filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Fournier Thomas MedGen due?
Fournier Thomas MedGen must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.